Interaction of lipoteichoic acid and CpG-DNA during activation of innate immune cells

Immunobiology

Volumn 206, Issue 4, 2002, Pages 392-407

  Dalpke, Alexander H ^a   Frey, Markus ^a   Morath, Siegfried ^b   Hartung, Thomas ^b   Heeg, Klaus ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYTOKINE; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 6; LIPOTEICHOIC ACID; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; PROTEIN P40; SYNAPTOPHYSIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; CELL SURFACE RECEPTOR; CPG OLIGONUCLEOTIDE; CPG-OLIGONUCLEOTIDE; DROSOPHILA PROTEIN; INTERLEUKIN 12P40; LIPOPOLYSACCHARIDE; MEMBRANE PROTEIN; OLIGODEOXYRIBONUCLEOTIDE; PROTEIN SUBUNIT; TEICHOIC ACID;

ANIMAL CELL; ARTICLE; BACTERIAL IMMUNITY; BACTERIAL INFECTION; CELL ACTIVATION; CELL INTERACTION; CELL TYPE; CONTROLLED STUDY; CPG ISLAND; DENDRITIC CELL; DRUG POTENCY; EFFECTOR CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IN VITRO STUDY; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PATHOGENICITY; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SALMONELLA ENTERICA; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL LINE; DRUG EFFECT; DRUG INTERACTION; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; MACROPHAGE ACTIVATION; METABOLISM;

ANIMALS; CELL LINE; DENDRITIC CELLS; DROSOPHILA PROTEINS; DRUG INTERACTIONS; IMMUNITY, NATURAL; INTERLEUKIN-12; INTERLEUKIN-12 SUBUNIT P40; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; OLIGODEOXYRIBONUCLEOTIDES; PROTEIN SUBUNITS; RECEPTORS, CELL SURFACE; RNA, MESSENGER; TEICHOIC ACIDS; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036775536     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1078/0171-2985-00189     Document Type: Article

References (43)

1. MEDZHITOV, R., and C. A. JANEWAY. 1997. Innate immunity: the virtues of a nonclonal system of recognition. Cell 91: 295.
2. AKIRA, S., K. TAKEDA, and T KAISHO. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2: 675.
3. KOPP, E. B., and R. MEDZHITOV. 1999. The Toll-receptor family and control of innate immunity. Curr. Opin. Immunol. 11: 13.
4. ADEREM, A., and R. J. ULEVITCH. 2000. Toll-like receptors in the induction of the innate immune response. Nature 406: 782.
5. POLTORAK, A., X. HE, I. SMIRNOVA, M. Y. LIU, C. V. HUFFEL, X. DU, D. BIRDWELL, E. ALEJOS, M. SILVA, C. GALANOS, M. FREUDENBERG, P. RICCIARDI-CASTAGNOLI, B. LAYTON, and B. BEUTLER. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085.
6. HOSHINO, K., O. TAKEUCHI, T. KAWAI, H. SANJO, T. OGAWA, Y. TAKEDA, K. TAKEDA, and S. AKIRA. 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162: 3749.
7. TAKEUCHI, O., K. HOSHINO, T. KAWAI, H. SANJO, H. TAKADA, T. OGAWA, K. TAKEDA, and S. AKIRA. 1999. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11: 443.
8. MORATH, S., A. GEYER, and T. HARTUNG. 2001. Structure-Function Relationship of Cytokine Induction by Lipoteichoic Acid from Staphylococcus aureus. J. Exp. Med. 193: 393.
9. SCHWANDNER, R., R. DZIARSKI, H. WESCHE, M. ROTHE, and C. J. KIRSCHNING. 1999. Peptidoglycan- and Lipoteichoic Acid-induced Cell Activation Is Mediated by Toll-like Receptor 2. J. Biol. Chem. 274: 17406.
10. LEHNER, M. D., S. MORATH, K. S. MICHELSEN, R. R. SCHUMANN, and T. HARTUNG. 2001. Induction of Cross-Tolerance by Lipopolysaccharide and Highly Purified Lipoteichoic Acid Via Different Toll-Like Receptors Independent of Paracrine Mediators. J. Immunol. 166: 5161.
11. OPITZ, B., N. W. SCHRODER, I. SPREITZER, K. S. MICHELSEN, C. J. KIRSCHNING, W. HALLATSCHEK, U. ZAHRINGER, T. HARTUNG, U. B. GOBEL, and R. R. SCHUMANN. 2001. Toll-like receptor-2 mediates Treponema glycolipid and lipoteichoic acid-induced NF-kappaB translocation. J. Biol. Chem. 276: 22041.
12. KRIEG, A. M., A. K. YI, S. MATSON, T. J. WALDSCHMIDT, G. A. BISHOP, R. TEASDALE, G. A. KORETZKY, and D. M. KLINMAN. 1995. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374: 546.
13. HEMMI, H., O. TAKEUCHI, T. KAWAI, T. KAISHO, S. SATO, H. SANJO, M. MATSUMOTO, K. HOSHINO, H. WAGNER, K. TAKEDA, and S. AKIRA. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408: 740.
14. KREUTZ, M., U. ACKERMANN, S. HAUSCHILDT, S. W. KRAUSE, D. RIEDEL, W. BESSLER, and R. ANDREESEN. 1997. A comparative analysis of cytokine production and tolerance induction by bacterial lipopeptides, lipopolysaccharides and Staphyloccous aureus in human monocytes. Immunology 92: 396.
15. COWDERY, J. S., N. J. BOERTH, L. A. NORIAN, P. S. MYUNG, and G. A. KORETZKY. 1999. Differential regulation of the IL-12 p40 promoter and of p40 secretion by CpG DNA and lipopolysaccharide. J. Immunol. 162: 6770.
16. HERMANN, C., I. SPREITZER, N. W. SCHRODER, S. MORATH, M. D. LEHNER, W. FISCHER, C. SCHUTT, R. R. SCHUMANN, and T. HARTUNG. 2002. Cytokine induction by purified lipoteichoic acids from various bacterial species - Role of LBP, sCD14, CD14 and failure to induce IL-12 and subsequent IFN-[gamma] release. Eur. J. Immunol. 32: 541.
17. SING, A., T. MERLIN, H. P. KNOPF, P. J. NIELSEN, H. LOPPNOW, C. GALANOS, and M. A. FREUDENBERG. 2000. Bacterial induction of beta interferon in mice is a function of the lipopolysaccharide component. Infect. Immun. 68: 1600.
18. ZIMMERMANN, S., O. EGETER, S. HAUSMANN, G. B. LIPFORD, M. ROECKEN, H. WAGNER, and K. HEEG. 1998. Cutting edge: CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. J. Immunol. 160: 3627.
19. . DAVIS, H. L., R. WEERANTA, T. J. WALDSCHMIDT, SCHORR J. TYGRETT L, and A. M. KRIEG. 1998. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 160: 870.
20. GAO, J. J., E. G. ZUVANICH, Q. XUE, D. L. HORN, R. SILVERSTEIN, and D. C. MORRISON. 1999. Cutting Edge: Bacterial DNA and LPS Act in Synergy in Inducing Nitric Oxide Production in RAW 264.7 Macrophages. J. Immunol. 163: 4095.
21. GAO, J. J., Q. XUE, C. J. PAPASIAN, and D. C. MORRISON. 2001. Bacterial DNA and lipopolysaccharide induce synergistic production of TNF-alpha through a post-transcriptional mechanism. J. Immunol. 166: 6855.
22. CRABTREE, T. D., L. JIN, D. P. RAYMOND, S. J. PELLETIER, C. W. HOULGRAVE, T. G. GLEASON, T. L. PRUETT, and R. G. SAWYER. 2001. Preexposure of murine macrophages to CpG oligonucleotide results in a biphasic tumor necrosis factor alpha response to subsequent lipopolysaccharide challenge. Infect. Immun. 69: 2123.
23. YI, A. K., J. G. YOON, S. C. HONG, T. W. REDFORD, and A. M. KRIEG. 2001. Lipopolysaccharide and CpG DNA synergize for tumor necrosis factor-alpha production through activation of NF-kappaB. Int. Immunol. 13: 1391.
24. ZHANG, H., J. W. PETERSON, D. W. NIESEL, and G. R. KLIMPEL. 1997. Bacterial lipoprotein and lipopolysaccharide act synergistically to induce lethal shock and proinflammatory cytokine production. J. Immunol. 159: 4868.
25. YANG, S., R. TAMAI, S. AKASHI, O. TAKEUCHI, S. AKIRA, S. SUGAWARA, and H. TAKADA. 2001. Synergistic effect of muramyldipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture. Infect. Immun. 69: 2045.
26. FLAK, T. A., L. N. HEISS, J. T. ENGLE, and W. E. GOLDMAN. 2000. Synergistic epithelial responses to endotoxin and a naturally occurring muramyl peptide. Infect. Immun. 68: 1235.
27. KENGATHARAN, K. M., S. DE KIMPE, C. ROBSON, S. J. FOSTER, and C. THIEMERMANN. 1998. Mechanism of gram-positive shock: identification of peptidoglycan and lipoteichoic acid moieties essential in the induction of nitric oxide synthase, shock, and multiple organ failure. J. Exp. Med. 188: 305.
28. HÄCKER, H., H. MISCHAK, G. HAECKER, S. ESER, N. PRENZEL, A. ULLRICH, and H. WAGNER. 1999. Cell type-specific activation of mitogen-activated protein kinases by CpG-DNA controls interleukin-12 release from antigen-presenting cells. EMBO J. 18: 6973.
29. RE, F., and J. L. STROMINGER. 2001. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J. Biol. Chem. 276: 37692.
30. KADOWAKI, N., S. Ho, S. ANTONENKO, M. R. DE WAAL, R. A. KASTELEIN, F. BAZAN, and Y. J. LIU. 2001. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194: 863.
31. HÄCKER, H., T. MIETHKE MISCHAK H, S. LIPTAY, R. SCHMID, T. SPARWASSER, K. HEEG, G. B. LIPFORD, and H. WAGNER. 1998. CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J. 17: 101.
32. CHU, W. M., X. GONG, Z. W. LI, K. TAKABAYASHI, H. H. OUYANG, Y. CHEN, A. LOIS, D. J. CHEN, G. C. LI, M. KARIN, and E. RAZ. 2000. DNA-PKcs is required for activation of innate immunity by immunostimulatory DNA. Cell 103: 909.
33. YI, A. K., D. M. KLINMAN, T. L. MARTIN, S. MATSON, and A. M. KRIEG. 1996. Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway. J. Immunol. 157: 5394.
34. HORNG, T., G. M. BARTON, and R. MEDZHITOV. 2001. TIRAP: an adapter molecule in the Toll signaling pathway. Nat. Immunol. 2: 835.
35. FITZGERALD, K. A., E. M. PALSSON-MCDERMOTT, A. G. BOWIE, C. A. JEFFERIES, A. S. MANSELL, G. BRADY, E. BRINT, A. DUNNE, P. GRAY, M. T. HARTE, D. MCMURRAY, D. E. SMITH, J. E. Sims, T. A. BIRD, and L. A. O'NEILL. 2001. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413: 78.
36. SATO, S., F. NOMURA, T KAWAI, O. TAKEUCHI, P. F. MUHLRADT, K. TAKEDA, and S. AKIRA. 2000. Synergy and cross-tolerance between toll-like receptor (TLR) 2- and TLR4-mediated signaling pathways. J. Immunol. 165: 7096.
37. HUME, D. A., D. M. UNDERHILL, M. J. SWEET, A. O. OZINSKY, F. Y. LIEW, and A. ADEREM. 2001. Macrophages exposed continuously to lipopolysaccharide and other agonists that act via toll-like receptors exhibit a sustained and additive activation state. BMC. Immunol. 2: 11.
38. BEUTLER, B., and V. KRUYS. 1995. Lipopolysaccharide signal transduction, regulation of tumor necrosis factor biosynthesis, and signaling by tumor necrosis factor itself. J. Cardiovasc. Pharmacol. 25 Suppl 2: S1.
39. DUMITRU, C. D., J. D. CECI, C. TSATSANIS, D. KONTOYIANNIS, K. STAMATAKIS, J. H. LIN, C. PATRIOTIS, N. A. JENKINS, N. G. COPELAND, G. KOLLIAS, and P. N. TSICHLIS. 2000. TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell. 103: 1071.
40. BROOK, M., G. SULLY, A. R. CLARK, and J. SAKLATVALA. 2000. Regulation of tumour necrosis factor alpha mRNA stability by the mitogen-activated protein kinase p38 signalling cascade. FEBS. Lett. 483: 57.
41. DEAN, J. L., M. BROOK, A. R. CLARK, and J. SAKLATVALA. 1999. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J. Biol. Chem. 274: 264.
42. NOMURA, F., S. AKASHI, Y. SAKAO, S. SATO, T. KAWAI, M. MATSUMOTO, K. NAKANISHI, M. KIMOTO, K. MIYAKE, K. TAKEDA, and S. AKIRA. 2000. Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J. Immunol. 164: 3476.
43. VISINTIN, A., A. MAZZONI, J. H. SPITZER, D. H. WYLLIE, S. K. DOWER, and D. M. SEGAL. 2001. Regulation of Toll-like receptors in human monocytes and dendritic cells. J. Immunol. 166: 249.